Literature DB >> 9506572

Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage.

W H Schmitt1, E Csernok, S Kobayashi, A Klinkenborg, E Reinhold-Keller, W L Gross.   

Abstract

OBJECTIVE: To find serologic markers of disease activity in patients with Churg-Strauss syndrome (CSS) linked to possible pathogenetic mechanisms by studying endothelial cell damage (soluble thrombomodulin [sTM]) in relation to T cell and eosinophil activation markers (soluble interleukin-2 receptor [sIL-2R] and eosinophil cationic protein [ECP]), and the presence of autoantibodies (antineutrophil cytoplasmic antibodies [ANCA] and anti-endothelial cell antibodies [AECA]) during both active and inactive phases of disease.
METHODS: Sixteen consecutive patients who fulfilled the 1992 Chapel Hill definition of CSS were studied over a period of 4.5 +/- 3.9 years (mean +/- SD). ECP was detected by Columbo immunocapture (immunoCAP) assay, sIL-2R and sTM by enzyme-linked immunosorbent assay (ELISA), AECA by cell ELISA, and ANCA by indirect immunofluorescence and ELISA.
RESULTS: In patients with active disease, ECP (8.4 +/- 90 units/ml), sIL-2R (3,725 +/- 2,310 units/ml), and sTM levels (5.5 +/- 2.9 units/liter) were significantly elevated compared with those in remission. Levels of sIL-2R showed a close correlation with levels of sTM (r = 0.75, P < 0.05). Interestingly, during remission, sIL-2R levels remained elevated in 4 of 7 patients, although the erythrocyte sedimentation rate, C-reactive protein level, and sTM level returned to the normal range (levels > 1,000 units/ml were associated with relapse). ANCA were found in only 7 patients (4 had classic ANCA, 3 had perinuclear ANCA), and AECA in 11 sera from 8 patients. In contrast to AECA, ANCA were associated with active disease.
CONCLUSION: In its active state, CSS is associated with markedly increased levels of sIL-2R and ECP, indicating T cell and eosinophil activation. Elevated sTM is a sign of endothelial cell damage that can be closely linked to T cell activation, as indicated by increased sIL-2R levels.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9506572     DOI: 10.1002/1529-0131(199803)41:3<445::AID-ART10>3.0.CO;2-3

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  20 in total

Review 1.  Clinical utility of testing for antineutrophil cytoplasmic antibodies.

Authors:  D Vassilopoulos; G S Hoffman
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

2.  Serum biomarkers are similar in Churg-Strauss syndrome and hypereosinophilic syndrome.

Authors:  P Khoury; P Zagallo; C Talar-Williams; C S Santos; E Dinerman; N C Holland; A D Klion
Journal:  Allergy       Date:  2012-07-09       Impact factor: 13.146

3.  Inflammatory cells and cellular activation in the lower respiratory tract in Churg-Strauss syndrome.

Authors:  A Schnabel; E Csernok; J Braun; W L Gross
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

4.  Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitis.

Authors:  P Lamprecht; F Moosig; A Gause; K Herlyn; E Csernok; H Hansen; W L Gross
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

Review 5.  Churg-strauss syndrome: an update.

Authors:  Andy Abril
Journal:  Curr Rheumatol Rep       Date:  2011-12       Impact factor: 4.592

6.  Churg-Strauss presenting as acute coronary syndrome: sometimes it's zebras.

Authors:  Nicholaos Kakouros; Rachel Bastiaenen; Antonios Kourliouros; Lisa Anderson
Journal:  BMJ Case Rep       Date:  2011-04-13

7.  Increased serum high mobility group box-1 level in Churg-Strauss syndrome.

Authors:  T Taira; W Matsuyama; H Mitsuyama; K-I Kawahara; I Higashimoto; I Maruyama; M Osame; K Arimura
Journal:  Clin Exp Immunol       Date:  2007-05       Impact factor: 4.330

Review 8.  T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells?

Authors:  Benjamin Wilde; Marielle Thewissen; Jan Damoiseaux; Pieter van Paassen; Oliver Witzke; Jan Willem Cohen Tervaert
Journal:  Arthritis Res Ther       Date:  2010-02-24       Impact factor: 5.156

9.  An abdominal presentation of churg-strauss syndrome.

Authors:  J R E Rees; P Burgess
Journal:  Case Rep Med       Date:  2010-08-10

Review 10.  Eosinophils in vasculitis: characteristics and roles in pathogenesis.

Authors:  Paneez Khoury; Peter C Grayson; Amy D Klion
Journal:  Nat Rev Rheumatol       Date:  2014-07-08       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.